SEC
SlamSEC
SearchBrowseEarnings

Lexaria Bioscience Corp.

Nasdaq:LEXX
Pharmaceutical Preparations·KELOWNA, A1
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

20 shown
FiledDescription
12/16/25
1.01
Material Agreement
→
9/29/25
1.01
Material Agreement
→
9/25/25
1.02
Agreement Terminated
→
6/12/25
1.01
Material Agreement
→
4/28/25
1.01
Material Agreement
→
2/5/25
1.01
Material Agreement
→
↓ 14 more
CEO
Christopher Richard